EVs were prepared from the supernatant of primary astrocytes and by differential centrifugations as previously described (Hu et al., 2012 (link); Hu et al., 2013 (link); Hu et al., 2018 (link)). Briefly, primary astrocytes were treated with HIV Tat protein for 24 hours. Then, conditioned media were harvested, centrifuged at 1,000 g for 10 min to eliminate cells, and again spun at 10,000 g for 30 min, followed by filtration through 0.22 μm filter to remove cell debris. EVs were pelleted by ultracentrifugation (Beckman Ti70 rotor, Brea, CA, USA) at 100,000g for 70 min. EVs were assessed for their protein content using BCA Protein Assay Kit (Pierce, Rockford, IL, USA). TSG101 and CD63 were detected by western blot as exosome markers. EVs were further quantified using the ZetaView nanoparticle tracking analysis system (Particle Metrix, Mebane NC).